<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> Biochemistry Molecular Biology <br />  <br /> PITX2 Involved Stress Response Cultured <br /> Human Trabecular Meshwork Cells Regulation SLC13A3 <br /> M. Hermina Strungaru,1 Tim Footz,1 Yi Liu,2 Fred B. Berry,1,3 Pascal Belleau,4 <br /> Elena V. Semina,2,5 Vincent Raymond,4 Michael  Walter1 <br />  <br /> PURPOSE. Mutations PITX2 gene cause Axenfeld-Rieger <br /> syndrome (ARS) glaucoma. study, authors  <br /> vestigated genes directly regulated PITX2 transcription <br />                                                                                 T    PITX2 transcription factor identified causative <br />                                                                                      gene Axenfeld-Rieger syndrome (ARS; Mendelian Inher- <br />                                                                                 itance Man  180500) Semina et al.1 ARS rare <br /> factor gain insight mechanisms underlying                     autosomal dominant disorder affects anterior eye develop- <br /> disorders.                                                                      ment2 occur systemic findings. METHODS. RNA nonpigmented ciliary epithelium cells                         ocular findings include structural anomalies anterior <br /> transfected hormone-inducible PITX2 activated                       chamber angle aqueous drainage structures. Nonocular <br /> mifepristone subjected microarray analyses. Data                    features typically include facial, dental, umbilical defects. <br /> analyzed using dCHIP algorithms detect significant differ-                   recent study3 showed ARS associated ences expression. Genes significantly altered expres-                   approximately 75% risk glaucoma patients FOXC1 sion multiple microarray experiments presence                      PITX2 defects. Glaucoma, second leading cause blindness <br /> activated PITX2 subjected silico biochemical                     world,4 &#226;&#8364;&#8220; 6 important clinical conse- <br /> analyses validate direct regulatory targets.                     quence ARS.7,8 Glaucoma associated elevated <br /> target gene characterized studying effect                 intraocular pressure (IOP), regulated ciliary body  knockdown cell model oxidative stress,                      site aqueous humor production) limbal region  expression zebrafish embryos analyzed situ hy-                     includes trabecular meshwork), principal site aqueous <br /> bridization.                                                                    humor outflow.4,5 disease continue progress pa- <br /> RESULTS. Solute carrier family 13 sodium-dependent dicarboxy-                   tients IOP significantly reduced. Research  <br /> late transporter member 3 (SLC13A3) identified 1 47                   ducted past decades revealed oxidative <br /> potential PITX2 target genes ocular cells. PITX2 directly                    stress involved glaucoma pathogenesis.9 &#226;&#8364;&#8220;16 Identifying <br /> regulates SLC13A3 expression, demonstrated luciferase                     genes involved adult anterior segment function responses <br /> reporter chromatin immunoprecipitation assays. Reduc-                       oxidative stress greatly improve understanding tion PITX2 SLC13A3 levels small interfering RNA                        glaucoma pathology result finding better treatment <br /> (siRNA)-mediated knockdown augmented death trans-                        options. <br /> formed human trabecular meshwork cells exposed hydro-                            PITX2 protein contains conserved 60 <span id='am-38' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-39' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-42' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>amino acid</span> <br /> gen peroxide. Zebrafish slc13a3 expressed anterior ocular                 homeodomain paired-bicoid class responsible regions pattern similar pitx2.                                  DNA binding, localization nucleus, protein-protein <br /> CONCLUSIONS. results indicate SLC13A3 direct                      interaction.17 Point mutations PITX2 demon- <br /> downstream target PITX2 transcriptional regulation                  strated loss function mutations affecting DNA binding <br /> levels PITX2 SLC13A3 modulate responses oxidative                     transcriptional transactivation.1,18 &#226;&#8364;&#8220;27 Tight control stress ocular cells. (Invest Ophthalmol Vis Sci. 2011;52:                    PITX2 expression required normal development 7625&#226;&#8364;&#8220;7633) DOI:10.1167/iovs.10-6967                                             eye little activity transcription <br />                                                                                 factor results anterior segment defects glaucoma.24,28 <br />                                                                                 hypothesize altered regulation expression      Departments 1Medical Genetics 3Surgery, Univer-            PITX2 target genes adult tissues significant <br /> sity Alberta, Edmonton, Alberta, Canada; 2Department Pediatrics           impact development progression ARS-associated Children&#226;&#8364;&#8482;s Research Institute, Medical College Wisconsin             glaucoma reveal cellular pathways affected Children&#226;&#8364;&#8482;s Hospital Wisconsin, Milwaukee, Wisconsin; 4Department             primary glaucoma phenotypes. Molecular Medicine, Universite&#194;&#180; Laval, Que&#194;&#180;bec City, Quebec, Canada;             previously designed hormone-inducible transcription 5Department Cell Biology, Neurobiology Anatomy, Medical              factor expression discover target genes FOXC129 <br /> College Wisconsin, Milwaukee, Wisconsin. <br />      Supported Canadian Institute Health Research (MAW), <br />                                                                                 adapted identify PITX2 target <br /> Fonds la Recherche Sante&#194;&#180; du Que&#194;&#180;bec (PB, VR), National               genes ocular cells. report identification Institutes Health Grant EY015518 (EVS).                                      characterization Solute carrier family 13 sodium-depen- <br />      Submitted publication November 29, 2010; revised 17            dent dicarboxylate transporter member 3 (SLC13A3) gene <br /> June 2, 2011; accepted June 4, 2011.                                            directly regulated PITX2. protein product, NaDC3,      Disclosure: M.H. Strungaru,  T. Footz,  Y. Liu,                  implicated important transporter neuronal metabo-  F.B. Berry,  P. Belleau,  E.V. Semina,  V. <br /> Raymond,  M  Walter,                                                                                 lites30 regulate uptake <span id='am-26' about='obo:IMR_0100173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001700'><span id='am-27' property="rdfs:label" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasExactSynonym" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:id" content="IMR:0100173" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="glutathione" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasExactSynonym" content="L-Glutathione" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="L-Glutathione" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasExactSynonym" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-37' property="obo:IAO_0000115" content="A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides." datatype="xsd:string"></span>glutathione</span> (GSH)      Corresponding author: Michael  Walter, Department Medical             protect ocular oxidative stress.31 demonstrate Genetics, University Alberta, Edmonton, AB, Canada, T6G 2H7;                 time PITX2 SLC13A3 necessary cellular <br /> mwalter@ualberta.ca.                                                            responses oxidative insult hydrogen peroxide. <br />  <br /> Investigative Ophthalmology <span id='am-19' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-20' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>amp</span>; Visual Science, September 2011, Vol. 52,  10 <br /> Copyright 2011 Association Research Vision Ophthalmology,                                                               7625 <br />  7626     Strungaru et al.                                                                           IOVS, September 2011, Vol. 52,  10 <br />  <br /> METHODS                                                                  performed described previously27,33 using antibody (anti- <br />                                                                          Xpress; Invitrogen). <br /> Plasmids                                                                     Hormone induction recombinant PITX2 NPCE cells                                                                          subsequent RNA extraction microarray analysis performed     PITX2-HD-HR. PCR used amplify homeodomain (HD)            described previously.29 Statistically significant differences (P &#226;&#172;? 0.05) wild-type recombinant PITX2A.28 forward reverse primers       average normalized fluorescence intensity transcript  <br /> used 5&#226;&#172;&#732;-GAT CAT GGG CCC CAA AGG CAG CGG-3&#226;&#172;&#732; 5&#226;&#172;&#732;-ATG               tween hormone-inducible constructs vector sam- <br /> ATC CGG ACC GGG CTC CCT CTT TCT CCA TTT G-3&#226;&#172;&#732;. HD                     ples determined. Expression data Affymetrix (Santa Clara, <br /> fragment cloned pGEM-T vector (Promega, Madison, WI)        CA) microarrays log2-transformed analyzed using manufacturer&#226;&#8364;&#8482;s protocol subcloned frame       dCHIP software.34,35 Changes transcript levels compared <br /> ApaI/RsrII sites pcDNAFOXC1-HR29 (N-terminal Xpresstag; Invitro-      matched sets RNA transfected  vector vs. <br /> gen, Burlington,  Canada) replacing forkhead domain.              PITX2-HD-HR PITX2-HR) NPCE cells treated 100 &#226;?&#174;g/mL cyclo- <br />     PITX2-HR. BstBI site inserted amino acids 138          heximide 10&#226;&#171;&#186;8 M mifepristone. change expression  139 recombinant Xpress-PITX2A28 site-directed mutagenesis.     termined occurred 1.5-fold change expres- hormone-responsive (HR) <span id='am-55' about='obo:IMR_0100034' typeof='owl:Thing obo:IMR_0100033 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0000966 obo:IMR_0000001'><span id='am-56' property="rdfs:label" content="progesterone" datatype="xsd:string"></span><span id='am-57' property="oboInOwl:hasExactSynonym" content="4-Pregnene-3,20-dione" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:id" content="IMR:0100034" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-60' property="rdfs:label" content="4-Pregnene-3,20-dione" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasDbXref" content="KEGG:C00410" datatype="xsd:string"></span>progesterone</span> receptor binding domain         sion detected P &#226;&#172;?0.05 present 2 3 PCR cloned pSWITCH vector (Invitrogen)             comparisons using Affymetrix software (MAS5). <br /> cloned frame BstBI site. <br />     Xpress-PITX2C. PITX2C cDNA amplified RT-PCR                Silico Analyses <br /> human trabecular meshwork RNA (forward, 5&#226;&#172;&#732;-GAA TTC ATG AAC <br />                                                                          silico tissue expression profile gene determined TGC ATG AAA GGC CCG C-3&#226;&#172;&#732;; reverse, 5&#226;&#172;&#732;-CAG GCT CAA GTT ACA <br />                                                                          electronic search SOURCE database (http://genome- <br /> CAT 3&#226;&#172;&#732;) subcloned frame EcoRI sites pCI-HA- <br />                                                                          www5.stanford.edu/cgi-bin/source/sourceSearch). PITX2 DNA bind- <br /> PITX2A32 replace isoform specific region. PITX2C insert <br />                                                                          ing motif search upstream region genes performed using pCI-HA-PITX2C subcloned XbaI/EcoRI sites                                                                          RepeatMasker (http://www.repeatmasker.org), Possum (http://zlab. <br /> pcDNA4HisMaxA. Xpress-PITX2C mutants T30P, V45L, R52C <br />                                                                          bu.edu/&#226;&#172;&#402;mfrith/possum), Ensembl (http://www.ensembl.org/ produced subcloning XhoI/NarI fragment                                                                          index.html) Web sites bicoid binding site matrix (http:// <br /> pcDNA4HisMax-PITX2A mutant constructs.27 <br />                                                                          www.gene-regulation.com/cgi-bin/pub/databases/transfac/getTF.cgi? <br />     SLC13A3 Reporters. Different lengths region immedi- <br />                                                                          AC&#226;&#171;&#189;M00140). gene functions determined using GoSurfer <br /> ately upstream 5&#226;&#172;&#732;UTR human SLC13A3 transcript variant 1 <br />                                                                          (http://bioinformatics.bioen.uiuc.edu/gosurfer). <br /> (GenBank accession NM_022829) PCR amplified genomic <br /> DNA. primers used constructs &#226;&#171;&#186;403/&#226;&#171;&#185;165            Step Quantitative RT-PCR <br /> ward, 5&#226;&#172;&#732;-GCT AGC TCC ACT TTC AGG CTC GAG G-3&#226;&#172;&#732;; reverse, 5&#226;&#172;&#732;-CTC <br /> GAG GGA GGA GGC GTT ACC TTG G-3&#226;&#172;&#732;) &#226;&#171;&#186;163/&#226;&#171;&#185;165 (forward,                Total RNA extracted siRNA-transfected HTM cells (TRIzol <br /> 5&#226;&#172;&#732;-GCT AGC AGG GAG AGG GCG GGT TCC-3&#226;&#172;&#732;; reverse, 5&#226;&#172;&#732;-CTC GAG               Reagent; Invitrogen). standard 20 &#226;?&#174;L reverse transcription reaction <br /> GGA GGA GGC GTT ACC TTG G-3&#226;&#172;&#732;). SLC13A3 upstream elements             contained following components: 1 &#226;?&#174;g DNaseI-treated total RNA, subcloned vector (pGL3Basic; Promega). Deletion PITX2       500 ng oligo d(T), 0.5 mM   dNTPs, 1&#226;&#171;&#187; strand buffer, 0.01 M <br /> binding site generate &#226;&#171;&#186;163/&#226;&#171;&#185;165&#226;&#338;&#172; construct accom-           dithiothreitol, 40 U RNase inhibitor (RNaseOUT; Invitrogen), 200 <br /> plished using site-directed mutagenesis kit (QuikChange Lightning;     U reverse transcriptase (M-MLV; Invitrogen). Replicate reactions  <br /> Agilent Technologies, La Jolla, CA) following manufacturer&#226;&#8364;&#8482;s      reverse transcriptase used negative controls; 0.5 &#226;?&#174;L instructions. forward mutagenesis primer complementary        reaction used template 10 &#226;?&#174;L qPCR reactions using PCR <br /> pair 5&#226;&#172;&#732;-ACC CTC CCC CAG GCT GCG CCG GG-3&#226;&#172;&#732;.                           kit (QuantiTect SYBR Green; Qiagen) following primer sets: <br />     Plasmid DNA isolated (Maxiprep QIAprep Spin Miniprep          PITX2 (forward, 5&#226;&#172;&#732;-AGG CCA CTT TCC AGA GGA AC-3&#226;&#172;&#732;; reverse, <br /> kits; Qiagen , Mississauga,  Canada), open reading frames     5&#226;&#172;&#732;-CGC TCC CTC TTT CTC CAT TT-3&#226;&#172;&#732;; SLC13A3 (forward, 5&#226;&#172;&#732;-GGA CAC fully sequenced ensure integrity.                          TTG CTG GTC AAA GAC-3&#226;&#172;&#732;; reverse, 5&#226;&#172;&#732;-ATG GCT CAT GGA CTT GAG <br />                                                                          TGG-3&#226;&#172;&#732;); HPRT1 (forward, 5&#226;&#172;&#732;-GCC AGA CTT TGT TGG ATT TGA-3&#226;&#172;&#732;; <br /> Cell Culture Transfection                                            reverse, 5&#226;&#172;&#732;-GGC TTT GTA TTT TGC TTT TCC AG-3&#226;&#172;&#732;). Thermal cycling <br />                                                                          performed real-time PCR (7900HT Fast; Applied <br /> Human nonpigmented ciliary epithelial (NPCE) human trabecular        Biosystems, Carlsbad, CA) following conditions: 95&#194;&#176;C, 15 <br /> meshwork (HTM) cell lines cultured described previously.29       minutes; 40 cycles 94&#194;&#176;C, 15 seconds; 60&#194;&#176;C, 30 seconds; 72&#194;&#176;C, 30 <br /> Cells transfected plasmid DNA according reagent         seconds. relative quantity gene transcripts (PITX2 siRNA vs. <br /> manufacturer&#226;&#8364;&#8482;s protocols (FuGENE 6 [Roche, Laval, QC, Canada];        nontargeting siRNA samples), averaged quadruplicate reactions, <br /> TransIT-LT1 [Mirus Bio LLC, Madison, WI]).                               calculated equation 2-&#226;&#338;&#172;&#226;&#338;&#172;Ct, HPRT1 used     Small interfering RNA (siRNA) specific shared region   endogenous reference. <br /> isoforms human PITX2 custom ordered Ambion (Austin, <br /> TX) (sense, 5&#226;&#172;&#732;-CAG CCU GAA UAA CUU GAA Ctt-3&#226;&#172;&#732;; antisense, 5&#226;&#172;&#732;-GUU         Chromatin Immunoprecipitation <br /> CAA GUU AUU CAG GCU Gtt-3&#226;&#172;&#732;). siRNA specific human SLC13A3 custom ordered Thermo Fisher Scientific/Dharmacon (Lafay-       Chromatin immunoprecipitation (ChIP) performed using ChIP <br /> ette,  (sense, 5&#226;&#172;&#732;-GGA GGA AGA AUA AAU CUG AUU-3&#226;&#172;&#732;; antisense,          kit (Active Motif ChIP Express; Cedarlane Laboratories , Burling- <br /> 5&#226;&#172;&#732;-UCA GAU UUA UUC UUC CUC CUU-3&#226;&#172;&#732;). Nontargeting control siRNA           ton,  Canada) according manufacturer&#226;&#8364;&#8482;s protocol. NPCE cells <br /> (AM4611) purchased Ambion. siRNA transfection           grown 70% 80% confluence (&#226;&#172;&#402;6 &#226;&#171;&#187; 107 cells) 100-mm <br /> formed described previously29 according reagent manufac-       plates. ChIP reactions set adding protein G magnetic <br /> turer&#226;&#8364;&#8482;s protocol (Lipofectamine 2000; Invitrogen).                       beads, ChIP buffer 1, 6.3 &#226;?&#174;g sheared chromatin (&#226;&#172;&#402;300 &#226;&#8364;&#8220;1000 bp), <br />                                                                          protease inhibitor cocktail (P8340; Sigma-Aldrich Canada , <br />                                                                          Oakville,  Canada), 2 &#226;?&#174;g anti-PITX2 antibody (H00005308- <br /> Hormone-Inducible PITX2                                                                          M01; Abnova Corporation, Taipei, Taiwan), normal rabbit IgG antibody <br /> Microarray Analysis                                                      (10500C; Invitrogen), anti-acetyl-histone H3 antibody (Lys9; 9671; <br /> PITX2-HD-HR PITX2-HR constructs transfected NPCE           Cell Signaling Technology, , Danvers, MA). ChIP reaction did <br /> cells 2 &#226;?&#174;g plasmid DNA &#226;&#171;&#185; 6 &#226;?&#174;L transfection reagent 5 &#226;&#171;&#187; 105        contain antibody. 166-bp fragment SLC13A3 upstream <br /> cells/60-mm plate  4 &#226;?&#174;g DNA &#226;&#171;&#185; 12 &#226;?&#174;L reagent 106 cells/100-mm      region containing PITX2 binding site B amplified primers <br /> plate). cell protein extracts derived, immunoblotting     5&#226;&#172;&#732;-TCC ACT TTC AGG CTC AGA GG-3&#226;&#172;&#732; 5&#226;&#172;&#732;-GCA GCT GGC TTA TCC <br />  IOVS, September 2011, Vol. 52,  10                                                                     PITX2 Regulates SLC13A3              7627 <br />  <br /> TCT CC-3&#226;&#172;&#732;. 243-bp fragment containing PITX2 binding site amplified primers 5&#226;&#172;&#732;-AGT GCC TAA CTT TCT CCA ACG-3&#226;&#172;&#732; 5&#226;&#172;&#732;-CGC TCC ACA CCT TCT TGG-3&#226;&#172;&#732;. 277-bp control amplicon upstream region lacking predicted PITX2 binding sites amplified primers 5&#226;&#172;&#732;-TTT GTC TTG CCT GAA TGC TG-3&#226;&#172;&#732; 5&#226;&#172;&#732;-TGC <br /> ACA CTC GTC TCC AAG TC-3&#226;&#172;&#732;; fragment amplified genomic DNA ChIP input fraction immuno- <br /> purified samples. <br />  <br /> Transactivation Assays <br /> Transactivation assays performed described previously.27 <br /> Transfections performed triplicate NPCE HTM cells 24 plates (4 &#226;&#171;&#187; 104 cells/15-mm  using 160 ng                 FIGURE 1. Modular construction inducible PITX2 constructs. <br /> (pcDNA4HisMax) Xpress-PITX2C vector, 60 ng pGL3Basic-SLC13A3              construct PITX2-HR created inserting truncated form luciferase reporter plasmid, 20 ng pCMV&#226;?&#164; (Promega) transfection              hormone-responsive progesterone receptor LBD control, 0.72 &#226;?&#174;L transfection reagent. Cells harvested         DNA-binding HD OAR protein-protein interaction motif. 100 &#226;?&#174;L passive lysis buffer (Promega) 48 hours transfection.           DNA-binding specificity inducible FOXC1-HR construct Firefly luciferase activity measured luminometry (Turner           altered specific PITX2 replacing forkhead domain <br /> signs, Sunnyvale, CA) 10 &#226;?&#174;L protein lysate mixed 100 &#226;?&#174;L            (FHD) PITX2 HD, create PITX2-HD-HR construct. <br /> luciferase assay reagent (Promega) standardized &#226;?&#164;-ga- <br /> lactosidase (internal control) activity quantitated &#226;?&#164;-galactosidase <br /> enzyme assay (Promega) 75 &#226;?&#174;L protein lysate.                     primers used: forward, 5&#226;&#172;&#732;-GAG AAG ATC TGG CAT CAC AC-3&#226;&#172;&#732;; <br />                                                                              reverse, 5&#226;&#172;&#732;-ATC AGG TAG TCT GTC AGG TC-3&#226;&#172;&#732; (329 bp). situ <br /> Cell Viability Assay                                                         hybridization, zebrafish slc13a3 cDNA fragment PCR amplified <br />                                                                              using following primers: forward, 5&#226;&#172;&#732;-TGC AGC AGA AGC TAA AGC <br /> Cell viability assays performed HTM cells (2 &#226;&#171;&#187; 105 cells/          AA-3&#226;&#172;&#732;; reverse, 5&#226;&#172;&#732;-CTA AGC CGG ACT CCT CAC AG-3&#226;&#172;&#732; (495 bp,  <br /> 35-mm  using 2 &#226;?&#174;g/mL propidium iodide (P4170; Sigma-Aldrich)            compassing exons 7&#226;&#8364;&#8220;11). resultant fragment cloned described previously.36 Propidium iodide excluded viable cells      vector (pCRII-TOPO; Invitrogen), insert sequence verified penetrates cell membranes dying dead cells.                        direct automated DNA sequencing. Digoxigenin-labeled RNA <br />                                                                              probes synthesized vitro transcription, situ hybrid- <br /> Zebrafish Expression                                                         ization performed previously described.38 <br /> Zebrafish (Danio rerio) housed water 14-hour <br /> light/10-hour dark cycle; embryos acquired natural spawn- <br /> ing maintained 28.5&#194;&#176;C. developmental stage deter-             RESULTS <br /> mined time (hours postfertilization [hpf] days postfertilization) <br />                                                                              Identification PITX2 Target Genes morphologic criteria.37 experiments conducted accor- <br /> dance guidelines established Institutional Animal Care <br />                                                                              Hormone-Inducible Expression Use Committee Medical College Wisconsin, adhering           hormone-inducible constructs PITX2 used ARVO Statement Use Animals Ophthalmic Vision           experiments. construct, PITX2-HR, ligand binding <br /> Research.                                                                    domain (LBD) human progesterone receptor inserted <br />     RNA extracted zebrafish embryos harvested reagent            40 amino acids C-terminal homeobox Xpress-PITX2A <br /> (TRIzol; Invitrogen) using standard procedures. cDNA synthesized         (Fig. 1). construct, PITX2-HD-HR, replaced forkhead 1 &#226;?&#174;g total RNA reverse transcriptase (SuperScript III; Invit-      domain FOXC1-HR construct29 PITX2 homeodo- <br /> rogen) random hexamers. RT-PCR analysis expression,           main (Fig. 1), altering DNA-binding specificity following slc13a3 primers used: forward, 5&#226;&#172;&#732;-TGG AAA GAC AAG             modular protein; construct, LBD replaces inhibitory <br /> GGA AGG AA-3&#226;&#172;&#732;; reverse, 5&#226;&#172;&#732;-ATG GTT GGA AAG AGG CAC AC-3&#226;&#172;&#732; (254                domain FOXC1 backbone. hormone-inducible  <br /> bp, encompassing exons 1 2). &#226;?&#164;-actin control, following          structs produced proteins appropriate molecular weight  <br /> TABLE 1. Genes Regulated PITX2 Selected Analysis <br />  <br />                        Gene                                Gene Symbol                                      Function <br />  <br /> Coatomer protein complex, subunit gamma 2                     COPG2           Transport-protein, retrograde Golgi ER <br /> High-density lipoprotein binding protein (vigilin)            HDLBP           RNA binding, nucleic acid binding, <span id='am-7' about='obo:IMR_0001362' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="CHEBI:25054" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0001362" datatype="xsd:string"></span><span id='am-11' property="obo:IAO_0000115" content="Organic molecule that is insoluble in water but tends to dissolve in nonpolar organic solvent." datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="lipid" datatype="xsd:string"></span>lipid</span> transport, metabolism <br /> Kelch-like 3                                                  KLHL3           Protein binding <br /> Nucleoporin 133 kDa                                           NUP133          mRNA export nucleus, nucleocytoplasmic transport <br /> Poly(<span id='am-1' about='obo:IMR_0001360' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-2' property="rdfs:label" content="ADP" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasAlternativeId" content="IMR:0200375" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0001360" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="KEGG:C00008" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>ADP</span>-ribose) polymerase family, member 2                  PARP2           DNA binding, DNA repair, ribosyltransferase activity <br /> Pyruvate dehydrogenase phosphatase isoenzyme                  PDP2            Phosphatase activity, hydrolase activity, catalytic activity, <span id='am-13' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-14' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-16' property="rdfs:label" content="ion" datatype="xsd:string"></span><span id='am-17' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-18' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span>ion</span> <br />   2                                                                             binding (Mg) <br /> Phosphatidyl glycerophosphate synthase 1                      PGS1            Catalytic activity, metabolism <br /> Protein C receptor, endothelial (EPCR)                        PROCR           Receptor activity, inflammatory response, blood coagulation <br /> Regulating synaptic membrane exocytosis 4                     RIMS4           Exocytosis activity, neurotransmitter transporter <br /> Solute carrier family 13 member 3                             SLC13A3         Transport-protein, retrograde Golgi ER <br /> Tectorin beta                                                 TECTB           Transporter activity, ion transporter <br /> Translocase inner mitochondrial membrane 10                TIMM10          Protein transport <br />   homolog <br /> Tolloid-like 2                                                TLL2            Proteolysis, ion binding (Ca, Zn) <br /> Transmembrane protease, serine 2                              TMPRSS2         Peptidase activity, hydrolase activity, proteolysis, receptor activity <br /> Zinc finger protein 652                                       ZNF652          Nucleic acid binding, zinc ion binding <br />  7628      Strungaru et al.                                                                         IOVS, September 2011, Vol. 52,  10 <br />  <br /> TABLE 2. Quantitative RT-PCR HTM Cells Transfected 100 nM PITX2 siRNA versus Nontargeting Control siRNA <br />  <br />                    Average Ct                      &#226;&#338;&#172;Ct                             &#226;&#338;&#172;&#226;&#338;&#172;Ct                                     Relative Quantity <br /> Detector     (PITX2 siRNA reaction)       (detector vs. HPRT1)         (PITX2 siRNA vs. control siRNA)      &#226;&#338;&#172;&#226;&#338;&#172;Ct (SD)           (2&#226;&#180;&#353;&#226;&#338;&#172;&#226;&#338;&#172;Ct) <br />  <br /> PITX2                  17.77                       2.36                              1.54                      0.57                 0.34 <br /> SLC13A3                26.12                      10.71                              1.25                      0.86                 0.42 <br /> HPRT1                  15.41                       0.00                              0.00                      0.22                 1.00 <br />  <br />  <br /> transfected NPCE cells (Supplementary Data, http://www.iovs.               function, ocular expression, PITX2 DNA binding sites org/lookup/suppl/doi:10.1167/iovs.10-6967/-/DCSupplemental)                promoter region (Table 1) subjected Northern blot analysis  administration progesterone analog mifepristone          semiquantitative RT-PCR (Supplementary Data, http://www.iovs. <br /> (RU-486), transactivated luciferase reporter gene fourfold             org/lookup/suppl/doi:10.1167/iovs.10-6967/-/DCSupplemental). transfection vector (Supplementary                 chose characterize SLC13A3, Data, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.10-                mRNA transcript confirmed semiquantitative RT-PCR 6967/-/DCSupplemental). hormone-inducible expression sys-              increase response expression hormone-inducible <br /> tem previously used identify FOXC1 target genes.29 Mife-            PITX2A (data shown). Real-time step RT-PCR using <br /> pristone activated hormone-inducible constructs, allowing              HTM cells transfected siRNA showed production mRNA expressed directly response PITX2                 reduction PITX2 mRNA 34% control levels  iso- <br /> transcriptional regulation. addition cycloheximide elimi-           forms) led reduction SLC13A3 transcripts  isoforms) <br /> nated secondary induction events preventing new protein             42% control levels (Table 2).  PITX2 regulated translated. controls, NPCE cells transfected           expression SLC13A3 ocular cell lines examined. expression vector treated identical                    genomic sequence SLC13A3 investigated manner cycloheximide mifepristone. Total RNA samples              putative PITX2 DNA-binding sites using POSSUM Web site <br /> collected independent experiments subjected             interface. binding motifs 3000 <br /> microarray analysis. gene expression profile NPCE cells             bp upstream exon SLC13A3 transcript variant 1. induced PITX2 activation directly compared           putative PITX2 DNA-binding site position &#226;&#171;&#186;26, site NPCE cells transfected vector. genes differ-            (Fig. 2), highly conserved Pan troglodytes (chimpanzee), <br /> entially expressed 1.5-fold analyzed. Anal-       Macaca mulatta (rhesus monkey), Canis familiaris (dog) <br /> ysis 45,038 probe set identified 448 genes differentially           promoter regions (data shown). putative PITX2 DNA <br /> regulated response PITX2-HD-HR 97 genes differentially           binding motif position &#226;&#171;&#186;311, site B, highly conserved regulated response PITX2-HR. seven genes overlapped            P. troglodytes M. mulatta promoter regions (data data sets hormone-inducible constructs             shown). ChIP analysis NPCE cells performed test PITX2 (Supplementary Data, http://www.iovs.org/lookup/                  direct binding PITX2 SLC13A3 upstream region. <br /> suppl/doi:10.1167/iovs.10-6967/-/DCSupplemental).                          Upstream DNA sequences SLC13A3 containing PITX2 bind- <br />                                                                            ing site PITX2 binding site B amplified PCR SLC13A3 Direct Target Gene PITX2                                   ChIP samples treated PITX2 acetyl-histone H3 (Lys9) 47 genes altered expression presence induced            antibodies (Fig. 2), indicating fragments recovered <br /> PITX2 multiple microarray experiments selected fur-            PITX2-bound, transcriptionally active chromatin. nega- <br /> ther analysis. genes investigated silico anal-         tive control region (&#226;&#172;&#402;20 kb upstream, Possum-pre- <br /> yses expression eye consensus PITX2 DNA-                dicted PITX2 binding sites) amplified ChIP <br /> binding sequences (TAATCC, GGATTA, GGCTTAG CTAAGCC)                     sample, attesting specificity antibodies (data 5&#226;&#172;&#732; upstream region gene. genes known            shown). <br />  <br />  <br />  <br />  <br />                                                                                                           FIGURE 2. PITX2 binds SLC13A3 <br />                                                                                                           upstream elements. ChIP used                                                                                                           template standard PCR. Antibodies <br />                                                                                                           PITX2 acetyl-histone H3 <br />                                                                                                           (Lys9) (positive control transcrip- <br />                                                                                                           tionally active chromatin) yielded tem- <br />                                                                                                           plate fragments                                                                                                           SLC13A3 upstream region ampli- <br />                                                                                                           fied, corresponding putative PITX2 <br />                                                                                                           binding sites B. ChIP experi- <br />                                                                                                           ments conducted antibody                                                                                                           rabbit IgG served negative  <br />                                                                                                           trols. putative PITX2 binding sites <br />                                                                                                           upstream ATG start codon                                                                                                           represented vertical lines,                                                                                                           horizontal line, <br />                                                                                                           corresponding forward  <br />                                                                                                           verse orientation, respectively.                                                                                                           length line represents log- <br />                                                                                                           likelihood ratio score calculated                                                                                                           POSSUM. <br />  IOVS, September 2011, Vol. 52,  10                                                         PITX2 Regulates SLC13A3          7629 <br />  <br />  <br />  <br />  <br /> FIGURE 3. Transcriptional transacti- <br /> vation effects PITX2 SLC13A3 <br /> upstream elements. Luciferase  <br /> porter plasmids  pGL3Basic)  <br /> taining different deletion constructs SLC13A3 upstream region cotransfected   NPCE (B) HTM cells pcDNA4 <br /> vector, Xpress-PITX2C, dif- <br /> ferent ARS-associated homeodomain <br /> missense mutations (T30P, V45L, R52C). transfection  <br /> formed triplicate. error bars <br /> represent relative SEM. *P &#226;&#172;? <br /> 0.05, calculated Student&#226;&#8364;&#8482;s t- <br /> test. <br />  <br />  <br />     Activation SLC13A3 upstream region PITX2 tested   oxidative stress response pathways. tested cyto- luciferase reporter assays NPCE HTM cells (Fig. 3).   toxic concentrations hydrogen peroxide (200, 400, 600, longest construct, &#226;&#171;&#186;403/&#226;&#171;&#185;165, included putative PITX2       800 &#226;?&#174;M <span id='am-50' about='obo:IMR_0200487' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-51' property="oboInOwl:id" content="IMR:0200487" datatype="xsd:string"></span><span id='am-52' property="rdfs:label" content="H2O2" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasDbXref" content="KEGG:C00027" datatype="xsd:string"></span>H2O2</span>) HTM cells; 600 &#226;?&#174;M H2O2 significant <br /> DNA-binding sites, (5&#226;&#172;&#732;-TTAAGCCG-3&#226;&#172;&#732;) B (5&#226;&#172;&#732;-TTAATCCT-3&#226;&#172;&#732;).       effect cell viability (Supplementary Data, http://www.iovs. second construct, &#226;&#171;&#186;163/&#226;&#171;&#185;165, contained binding site        org/lookup/suppl/doi:10.1167/iovs.10-6967/-/DCSupplemental).  &#226;&#171;&#186;163/&#226;&#171;&#185;165&#226;&#338;&#172; deleted binding site  Wild-          performed cell viability assays test reduc- <br /> type recombinant PITX2C caused approximately 7- 12-fold          tion PITX2 levels influenced survival response activation reporters containing binding site       oxidative stress. shown Figure 4, HTM cells significantly reduced approximately 4.5-fold site     transfected 100 nM PITX2 siRNA exposed H2O2, <br /> deleted. Activation PITX2-responsive reporters greatly   number nonviable HTM cells significantly increased <br /> diminished disease-causing mutant constructs PITX2C         times compared cells treated nontar- <br /> (T30P, V45L, R52C) used.                                   geting control siRNA H2O2. investigated                                                                     reduction SLC13A3 levels influenced survival  <br /> PITX2 SLC13A3 Involved Stress                          sponse oxidative stress. Transfection HTM cells 100 nM <br /> Response Pathway                                                    SLC13A3 siRNA caused 72% reduction endogenous RNA <br /> Recent data indicate local oxidative stress determining   levels 84% reduction recombinant protein levels (Sup- <br /> factor pathology glaucoma.13&#226;&#8364;&#8220;15 inves-       plementary Data, http://www.iovs.org/lookup/suppl/doi: <br /> tigated PITX2 SLC13A3 involved ocular           10.1167/iovs.10-6967/-/DCSupplemental). observed sig- <br />  7630    Strungaru et al.                                                                 IOVS, September 2011, Vol. 52,  10 <br />  <br />  <br />  <br />  <br />                                                                                                 FIGURE 4. PITX2 SLC13A3                                                                                                 involved stress response HTM <br />                                                                                                 cells. HTM cells transfected 100 <br />                                                                                                 nM siRNA treated 48 hours later <br />                                                                                                 600 &#226;?&#174;M H2O2, cell viability <br />                                                                                                 assessed. Nonviable cells  <br />                                                                                                 tected propidium iodide staining 24 <br />                                                                                                 hours H2O2 exposure.   Repre- <br />                                                                                                 sentative fluorescence photomicro- <br />                                                                                                 graphs HTM cells, nuclei coun- <br />                                                                                                 terstained DAPI. (B) Quantification <br />                                                                                                 nonviable cells counting cells                                                                                                 representative fields. Data                                                                                                 presented mean &#226;&#171;&#190; SD                                                                                                 experiments. *P &#226;&#172;? 0.05, Student&#226;&#8364;&#8482;s <br />                                                                                                 t-test. <br />  <br />  <br /> nificant twofold reduction cell viability H2O2-trea-        DISCUSSION <br /> ted HTM cells transfected SLC13A3 <br /> siRNA compared nontargeting control siRNA                    Mutations PITX2 cause ARS, human autosomal dominantly <br /> (Fig. 4).                                                         inherited maldevelopment disorder eye associated                                                                   glaucoma. defects PITX2 disrupt developing                                                                   mature eye leading human disease remains unknown. PITX2 <br /> Analysis slc13a3 Expression Zebrafish <br />                                                                   key roles developing eye Pitx2&#226;&#171;&#186;/&#226;&#171;&#186; knockout mice characterized expression slc13a3 homolog ze-         present severe ocular defects, including agenesis brafish (Fig. 5A) gain better understanding physio-   cornea, abnormal blood vessels, dysgenic optic nerve, logical role relation expression pitx2. RT-PCR       coloboma.40  PITX2 expression maintained analysis detected slc13a3 transcripts zebrafish embryos        adult eye, recent experiments extraocular muscles <br /> starting 12 hpf (Fig. 5B). mount situ hybridiza-    mice showed Pitx2 important birth.41 Loss <br /> tion detected enrichment slc13a3 transcripts hatch-    Pitx2 postnatally affected extraocular muscle function, mak- <br /> ing gland, fins, pharyngeal arches, periocular mesenchyme     ing extraocular muscles fatigable wild-type 27 hpf pharynx, kidney, gut, anterior segment   mice. Furthermore, glaucoma usually develops patients eye region 120 hpf embryos (Fig. 5C). Expression     PITX2 defects early 20s 30s (early onset) developing kidney gut appeared strongest,       birth (congenital). results indicate PITX2 particularly later stages embryonic development.        important embryogenesis important  localization slc13a3 anterior ocular regions coin-    normal function adult eye. identified <br /> cides remarkably pitx2 expression devel-     PITX2 target genes adult eye cells use opmental stages.38,39                                             hormone-inducible expression elucidate gene <br />  IOVS, September 2011, Vol. 52,  10                                                                   PITX2 Regulates SLC13A3             7631 <br />  <br />  <br />  <br />  <br /> FIGURE 5. Analysis zebrafish slc13a3 expression.   Alignment zebrafish human slc13a3/SLC13A3 amino acid sequences (&#226;&#172;&#402;70% <br /> identical). (B) Zebrafish slc13a3 transcript detected 12 hpf using RT-PCR. (C) situ hybridization demonstrates expression slc13a3 <br /> transcript mount images transverse sections zebrafish embryos. hg, hatching gland; pa, pharyngeal arches; f, fin; pm, periocular <br /> mesenchyme;  anterior segment; p, pharynx; k, kidney; hpf, hours postfertilization. <br />  <br /> regulatory pathways necessary normal anterior segment                  resulting hyperphosphorylation inactivation py- <br /> function.                                                                  ruvate dehydrogenase complex.49,50 results     Target genes PITX2 regulation different cell types          SLC13A3 direct target PITX2 regulation. SLC13A3  identified previously microarray analyses. Al-                codes transmembrane protein, NaDC3, acts Na&#226;&#171;&#185;/ did detect overlap muscle-specific               dicarboxylate cotransporter. Mammalian NaDC3 expressed <br /> genes expression correlated Pitx2 gene dosage42                 liver, kidney,51 brain,52 eye, optic nerve,30,53 data set, genes list 47 potential direct           demonstrate localization zebrafish slc13a3 targets  e., PCDP1/MGC33657 TLL2) common                     similar tissues. notably, pattern expression expression HEK293 cells altered                    periocular mesenchyme anterior ocular segment recombinant PITX2 expression.43 Additional direct               different stages development overlaps remarkably target genes PITX2 regulation previously identi-              zebrafish pitx2.38,39 situ hybridization adult mouse <br /> fied, including PLOD-1,44 Lef-1,45 FoxJ1,46 Dkk2,47                eye showed NaDC3 mRNA present anterior detected microarray experiments.                  posterior segments. postulated role NaDC3 kidney cells extensively characterized physically associated transcrip-            transport GSH,31 main defense mechanisms tion factors complex pitx2-foxc1-foxc2-pawr regulatory                human body oxidative stress. Aqueous humor network involved zebrafish ocular development.48 iden-              glaucoma patients presents reduced total antioxidant po- <br /> tification SLC13A3 ocular target gene PITX2               tential54 decreased plasma GSH levels.55 SLC13A3 provides important tool monitor output                hypothesized contribute maintenance visual func- <br /> modifications regulatory network.                                  tion role transporting neuronal metabolite <br />     PITX2 target genes identified (Table 1)               N-acetylaspartic acid (NAA) plasma membrane functions relevant glaucoma pathology. example,                ocular tissues.30 Mutations gene encoding aspartoacy- <br /> levels pyruvate dehydrogenase phosphatase (PDP2)                 lase, hydrolyses intracellular NAA, cause Canavan dis- <br /> creased response stresses starvation diabetes             ease, autosomal recessive disorder associated optic <br />  7632    Strungaru et al.                                                                       IOVS, September 2011, Vol. 52,  10 <br />  <br /> neuropathy, mental retardation, brain degeneration.56        sponses SLC13A3. analyzed expres- <br /> potential roles SLC13A3 oxidative stress optic      sion zebrafish slc13a3 able monitor  <br /> neuropathy caused Canavan disease indicate SLC13A3           sponse modulation levels pitx2 members <br /> good candidate involvement glaucoma.                          regulatory gene network. <br />     observed decreased SLC13A3 expression endog- <br /> enous PITX2 levels reduced increased SLC13A3 ex- <br />                                                                      Acknowledgments <br /> pression recombinant PITX2 activity increased. Mo- <br /> lecular analyses indicated PITX2  isoform C            authors thank Yu tissue culture expertise. <br /> tested) significantly activated transcription reporter plas- <br /> mids containing SLC13A3 upstream elements, PITX2 <br />                                                                      References <br /> mutants did  detected binding endogenous <br /> PITX2 SLC13A3 promoter region elements ChIP.               1. Semina EV, Reiter R, Leysens NJ, et al. Cloning characterization <br /> SLC13A3 mRNA expressed ciliary body, site               novel bicoid-related homeobox transcription factor gene, <br /> aqueous humor production;  protein encoded              RIEG, involved Rieger syndrome. Nat Genet. 1996;14:392&#226;&#8364;&#8220;399. <br /> SLC13A3 important functions production           2. Gould DB, Smith RS, John SW. Anterior segment development <br /> aqueous humor. Mutations downregulation SLC13A3                relevant glaucoma. Int J Dev Biol. 2004;48:1015&#226;&#8364;&#8220;1029. <br /> result increased IOP glaucoma.                                 3. Strungaru MH, Dinu  Walter MA. Genotype-phenotype correla- <br />     analyses indicate PITX2 activates genes              tions Axenfeld-Rieger malformation glaucoma patients                                                                          FOXC1 PITX2 mutations. Invest Ophthalmol Vis Sci. 2007;48: <br /> anterior segment eye involved variety key pro- <br />                                                                          228 &#226;&#8364;&#8220;237. <br /> cesses, including response cellular stress. Cellular stress                                                                       4. Allingham, RR. Shields&#226;&#8364;&#8482; Textbook Glaucoma. Philadelphia: Lip- induced generation reactive oxygen species                  pincott Williams &amp; Wilkins; 2005:1&#226;&#8364;&#8220;2. <br /> (ROS), experimental studies shown local            5. Gupta D. Glaucoma Diagnosis Management. Philadelphia: <br /> oxidative stress induced ROS determining factor           Lippincott Williams &amp; Wilkins; 2005:3. <br /> pathology glaucoma. vitro studies shown TM            6. Resnikoff, S, Pascolini, D, Etya&#226;&#8364;&#8482;ale, D, et al. Global data visual <br /> cell morphology altered exposure hydrogen peroxide              impairment year 2002. Bull World Health Organ. 2004;82: compromising cellular integrity cell adhesion.14               844 &#226;&#8364;&#8220; 851. <br /> addition, aqueous humor drainage anterior chamber            7. Reese AB, Ellsworth RM. anterior chamber cleavage syn- calf eye affected TM cells perfused              drome. Arch Ophthalmol. 1966;75:307&#226;&#8364;&#8220;318. <br /> hydrogen peroxide.15  shown humans            8. Fitch N, Kaback M. Axenfeld syndrome Rieger syn- TM cells glaucoma patients presented oxidative            drome. J Med Genet. 1978;15:30 &#226;&#8364;&#8220;34. <br /> DNA damage unaffected controls, damage               9. Shen F, Chen B, Danias J, et al. Glutamate-induced glutamine <br /> significantly correlated elevation IOP visual            synthetase expression retinal Muller cells short-term ocular <br /> field damage.13,16 studies indicate reduction PITX2          hypertension rat. Invest Ophthalmol Vis Sci. 2004;45:3107&#226;&#8364;&#8220; <br />                                                                          3112. <br /> protein levels produced increase cultured trabecular <br />                                                                      10. Galassi F, Renieri G, Sodi  Ucci F, Vannozzi L, Masini E. Nitric <br /> meshwork cell death siRNA-transfected cells                oxide proxies ocular perfusion pressure primary open angle <br /> exposed hydrogen peroxide.  reduction                   glaucoma. Br J Ophthalmol. 2004;88:757&#226;&#8364;&#8220;760. <br /> SLC13A3 produced increase HTM cell death             11. Chung HS, Harris  Evans DW, Kagemann L, Garzozi HJ, Martin, B. cells exposed hydrogen peroxide. results               Vascular aspects pathophysiology glaucomatous optic <br /> support hypothesis PITX2 acts SLC13A3                neuropathy. Surv Ophthalmol. 1999;43(suppl 1):S43&#226;&#8364;&#8220;S50. <br /> modulate responses cellular stress. speculate          12. Moreno MC, Campanelli J, Sande P, et al. Retinal oxidative stress <br /> healthy adults, PITX2 activates SLC13A3 encoded pro-               induced high intraocular pressure. Free Radic Biol Med. 2004; <br /> tein, NaDC3, transports GSH aqueous humor                  37:803&#226;&#8364;&#8220; 812. <br /> trabecular meshwork cells. GSH protect cells       13. Izzotti  Sacca SC, Cartiglia C, Flora S. Oxidative deoxyribo- accumulation ROS, maintaining normal trabecular mesh-             nucleic acid damage eyes glaucoma patients. J Med. <br /> work function normal drainage aqueous humor                  2003;114:638 &#226;&#8364;&#8220; 646. <br /> normal IOP. certain ARS patients speculate             14. Zhou L, Li Y, Yue  Oxidative stress affects cytoskeletal structure <br /> addition causing structural defects anterior segment           cell-matrix interactions cells ocular tissue:                                                                          trabecular meshwork. J Cell Physiol. 1999;180:182&#226;&#8364;&#8220;189. <br /> development, mutations PITX2 cause persistently  <br />                                                                      15. Kahn MG, Giblin FJ, Epstein DL. <span id='am-45' about='obo:IMR_0200318' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-46' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="Glutathione" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:id" content="IMR:0200318" datatype="xsd:string"></span>Glutathione</span> calf trabecular <br /> duced SLC13A3 expression resulting decreased GSH trans-               meshwork relation aqueous humor outflow facility. <br /> port trabecular meshwork cells. consequence,                 Invest Ophthalmol Vis Sci. 1983;24:1283&#226;&#8364;&#8220;1287. <br /> defense mechanism ROS accumulation compro-                16. Sacca SC, Pascotto  Camicione P, Capris P, Izzotti  Oxidative <br /> mised,  ROS generation exceeds cell&#226;&#8364;&#8482;s antioxi-              DNA damage human trabecular meshwork: clinical correla- <br /> dant capacity, ROS cause cell dysfunction cell death.            tion patients primary open-angle glaucoma. Arch Ophthal- <br /> number dead cells increased time, resulting           mol. 2005;123:458 &#226;&#8364;&#8220; 463. <br /> compromised aqueous humor drainage, elevated IOP, glau-          17. Walter MA. PITs FOXes ocular genetics: Cogan Lecture. <br /> coma. biochemical model glaucoma progression chal-               Invest Ophthalmol Vis Sci. 2003;44:1402&#226;&#8364;&#8220;1405. <br /> lenges notion ARS classified solely secondary       18. Lines MA, Kozlowski K, Kulak SC, et al. Characterization form glaucoma.                                                        prevalence PITX2 microdeletions mutations Axenfeld- <br />     summary, identified PITX2 target genes              Rieger malformations. Invest Ophthalmol Vis Sci. 2004;45:828 &#226;&#8364;&#8220; <br /> NPCE cell line use hormone-inducible expres-            833. <br /> sion microarray analysis. method             19. Kulharya  Maberry M, Kukolich MK, et al. Interstitial deletions <br />                                                                          4q21.1q25 4q25q27: phenotypic variability relation successfully used identify genes direct targets         Rieger anomaly. J Med Genet. 1995;55:165&#226;&#8364;&#8220;170. transcriptional regulation FOXC129 PITX2.       20. Alward WL, Semina EV, Kalenak JW, et al. Autosomal dominant iris <br /> result propose method generally applicable           hypoplasia caused mutation Rieger syndrome (RIEG/ isolate target genes transcription factors, depending           PITX2) gene. J Ophthalmol. 1998;125:98 &#226;&#8364;&#8220;100. DNA-binding specificity construct. Importantly,        21. Kulak SC, Kozlowski K, Semina EV, Pearce  Walter MA. Mu- shown SLC13A3 direct target gene PITX2             tation RIEG1 gene patients iridogoniodysgenesis PITX2 involved ocular oxidative cellular stress            syndrome. Hum Mol Genet. 1998;7:1113&#226;&#8364;&#8220;1117. <br />  IOVS, September 2011, Vol. 52,  10                                                                   PITX2 Regulates SLC13A3             7633 <br />  <br /> 22. Saadi  Semina EV, Amendt BA, et al. Identification dominant     39. Essner JJ, Branford WW, Zhang J, Yost HJ. Mesendoderm     negative homeodomain mutation Rieger syndrome. J Biol                   left-right brain, heart gut development differentially regu- <br />     Chem. 2001;276:23034 &#226;&#8364;&#8220;23041.                                               lated pitx2 isoforms. Development. 2000;127:1081&#226;&#8364;&#8220;1093. <br /> 23. Perveen R, Lloyd IC, Clayton-Smith J, et al. Phenotypic variability    40. Evans AL, Gage PJ. Expression homeobox gene Pitx2     asymmetry Rieger syndrome associated PITX2 muta-               neural crest required optic stalk ocular anterior segment <br />     tions. Invest Ophthalmol Vis Sci. 2000;41:2456 &#226;&#8364;&#8220;2460.                      development. Hum Mol Genet. 2005;14:3347&#226;&#8364;&#8220;3359. <br /> 24. Priston M, Kozlowski K, Gill D, et al. Functional analyses      41. Zhou Y, Cheng G, Dieter L, et al. altered phenotype     newly identified PITX2 mutants reveal novel molecular mecha-             conditional knockout Pitx2 extraocular muscle. Invest Oph- <br />     nism Axenfeld-Rieger syndrome. Hum Mol Genet. 2001;10:                 thalmol Vis Sci. 2009;50:4531&#226;&#8364;&#8220; 4541. <br />     1631&#226;&#8364;&#8220;1638.                                                             42. Diehl AG, Zareparsi S, Qian M, Khanna R, Angeles R, Gage PJ. <br /> 25. Phillips JC. novel mutations PITX2 gene patients            Extraocular muscle morphogenesis gene expression regu- <br />     Axenfeld-Rieger syndrome. Ophthalmic Res. 2002;34:324 &#226;&#8364;&#8220;               lated Pitx2 gene dose. Invest Ophthalmol Vis Sci. 2006;47: <br />     326.                                                                       1785&#226;&#8364;&#8220;1793. <br /> 26. Borges  Susanna R Jr, Carani JC, et al. Genetic analysis PITX2   43. Huang Y, Huang K, Boskovic G, et al. Proteomic genomic <br />     FOXC1 Rieger Syndrome patients Brazil. J Glaucoma. <br />                                                                                analysis PITX2 interacting regulating networks. FEBS Lett. <br />     2002;11:51&#226;&#8364;&#8220;56. <br />                                                                                2009;583:638 &#226;&#8364;&#8220; 642. <br /> 27. Footz T, Idrees F, Acharya M, Kozlowski K, Walter MA. Analysis                                                                            44. Hjalt TA, Amendt BA, Murray JC. PITX2 regulates procollagen lysyl <br />     mutations PITX2 transcription factor patients     Axenfeld-Rieger syndrome. Invest Ophthalmol Vis Sci. 2009;50:              hydroxylase (PLOD) gene expression: implications pathol- <br />     2599 &#226;&#8364;&#8220;2606.                                                                ogy Rieger syndrome. J Cell Biol. 2001;152:545&#226;&#8364;&#8220;552. <br /> 28. Kozlowski K, Walter MA. Variation residual PITX2 activity        45. Amen M, Liu X, Vadlamudi U, et al. PITX2 beta-catenin inter- <br />     derlies phenotypic spectrum anterior segment developmen-            actions regulate Lef-1 isoform expression. Mol Cell Biol. 2007;27: <br />     tal disorders. Hum Mol Genet. 2000;9:2131&#226;&#8364;&#8220;2139.                            7560 &#226;&#8364;&#8220;7573. <br /> 29. Berry FB, Skarie JM, Mirzayans F, et al. FOXC1 required cell    46. Venugopalan SR, Amen MA, Wang J, et al. Novel expression     viability resistance oxidative stress eye        transcriptional regulation FoxJ1 oro-facial morphogene- <br />     transcriptional regulation FOXO1A. Hum Mol Genet. 2008;17:              sis. Hum Mol Genet. 2008;17:3643&#226;&#8364;&#8220;3654. <br />     490 &#226;&#8364;&#8220;505.                                                              47. Gage PJ, Qian M, Wu D, Rosenberg KI. canonical Wnt signal- <br /> 30. George RL, Huang W, Naggar HA, Smith SB, Ganapathy V. Trans-               ing antagonist DKK2 essential effector PITX2 function <br />     port N-acetylaspartate murine sodium/dicarboxylate cotrans-         normal eye development. Dev Biol. 2008;317:310 &#226;&#8364;&#8220;324. <br />     porter NaDC3 expression transporter aspartoacy-        48. Acharya M, Huang L, Fleisch VC, Allison WT, Walter MA. com- <br />     lase II ocular tissues mouse. Biochim Biophys Acta. 2004;            plex regulatory network transcription factors critical ocular <br />     1690:63&#226;&#8364;&#8220; 69.                                                               development disease. Hum Mol Genet. 2011;20:1610 &#226;&#8364;&#8220;1624. <br /> 31. Lash LH. Role glutathione transport processes kidney func-       49. Huang B, Wu P, Popov KM, Harris RA. Starvation diabetes <br />     tion. Toxicol Appl Pharmacol. 2005;204:329 &#226;&#8364;&#8220;342.                           reduce pyruvate dehydrogenase phosphatase rat <br /> 32. Berry FB, Lines MA, Oas JM, et al. Functional interactions         heart kidney. Diabetes. 2003;52:1371&#226;&#8364;&#8220;1376. <br />     FOXC1 PITX2 underlie sensitivity FOXC1 gene dose         50. Wu P, Sato J, Zhao Y, Jaskiewicz J, Popov KM, Harris RA. Starvation <br />     Axenfeld-Rieger syndrome anterior segment dysgenesis. Hum              diabetes increase pyruvate dehydrogenase ki- <br />     Mol Genet. 2006;15:905&#226;&#8364;&#8220;919.                                                nase isoenzyme 4 rat heart. Biochem J. 1998;329(pt 1):197&#226;&#8364;&#8220;201. <br /> 33. Alvarez BV, Vithana  Yang  et al. Identification charac-      51. Chen X, Tsukaguchi H, Chen XZ, Berger UV, Hediger MA. Molec- <br />     terization novel mutation carbonic anhydrase IV gene           ular functional analysis SDCT2, novel rat sodium-depen- <br />     causes retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2007;         dent dicarboxylate transporter. J Clin Invest. 1999;103:1159 &#226;&#8364;&#8220; <br />     48:3459 &#226;&#8364;&#8220;3468. <br />                                                                                1168. <br /> 34. Li C, Hung Wong W. Model-based analysis oligonucleotide <br />                                                                            52. Huang W, Wang H, Kekuda R, et al. Transport N-acetylaspartate <br />     arrays: model validation, design issues standard error applica- <br />                                                                                Na(&#226;&#171;&#185;)-dependent high-affinity dicarboxylate transporter <br />     tion. Genome Biol. 2001;2:RESEARCH0032. <br />                                                                                NaDC3 relevance expression transporter 35. Li C, Wong WH. Model-based analysis oligonucleotide arrays: <br />                                                                                brain. J Pharmacol Exp Ther. 2000;295:392&#226;&#8364;&#8220; 403. <br />     expression index computation outlier detection. Proc Natl <br />     Acad Sci U S  2001;98:31&#226;&#8364;&#8220;36.                                         53. Chen XZ, Shayakul C, Berger UV, Tian W, Hediger MA. Character- <br /> 36. Yu AL, Fuchshofer R, Kampik  Welge-Lussen U. Effects oxi-             ization rat Na&#226;&#171;&#185;-dicarboxylate cotransporter. J Biol Chem. <br />     dative stress trabecular meshwork cells reduced prosta-          1998;273:20972&#226;&#8364;&#8220;20981. <br />     glandin analogues. Invest Ophthalmol Vis Sci. 2008;49:4872&#226;&#8364;&#8220;            54. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxida- <br />     4880.                                                                      tive stress markers aqueous humor glaucoma patients. J <br /> 37. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF.                 Ophthalmol. 2004;137:62&#226;&#8364;&#8220; 69. <br />     Stages embryonic development zebrafish. Dev Dyn.             55. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL. Sys- <br />     1995;203:253&#226;&#8364;&#8220;310.                                                          temic reduction glutathione levels occurs patients pri- <br /> 38. Volkmann BA, Zinkevich NS, Mustonen  et al. Potential novel              mary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005;46: <br />     mechanism Axenfeld-Rieger syndrome: deletion distant              877&#226;&#8364;&#8220; 883. <br />     region containing regulatory elements PITX2. Invest Ophthal-        56. Matalon R, Michals-Matalon K. Biochemistry molecular biology <br />     mol Vis Sci. 2011;52:1450 &#226;&#8364;&#8220;1459.                                           Canavan disease. Neuro <br /> </body></html>